Aarhus University Seal / Aarhus Universitets segl

Asbjørn Mohr Drewes

Effects of gabapentin on experimental somatic pain and temporal summation.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

  • Lars Arendt-Nielsen, Danmark
  • Jens Brøndum Frøkjaer, Danmark
  • Camilla Staahl, Danmark
  • Thomas Graven-Nielsen, Danmark
  • John P Huggins, Danmark
  • Trevor S Smart, Danmark
  • Asbjørn Mohr Drewes
  • Medicinsk Gastroenterologisk Afdeling, Medicinsk Center, Aalborg Sygehus
  • Center for visceral biomekanik og smerte, AAL
BACKGROUND AND OBJECTIVES: Gabapentin is used for treatment of neuropathic pain, but its effect on different somatic pain modalities and integrative mechanisms are not completely understood. The aim of this double-blind, placebo-controlled experimental pain study, conducted on 20 healthy volunteers, was to examine the effect of a single dose of 1200 mg gabapentin on multi-modal experimental cutaneous and muscle pain models. METHODS: The following pain models were applied: (1) pain thresholds to single and repeated cutaneous and intramuscular electrical stimulation (temporal summation to 5 stimuli delivered at 2 Hz); (2) stimulus-response function relating pain intensity scores (visual analog scale, VAS) to increasing current intensities for electrical skin and muscle stimuli (single and repeated, determined at baseline); and (3) the pain intensity (VAS) and pain areas after intramuscular injection of hypertonic saline. Pain assessments were performed prior to, and at 4, 6, and 8 hours after medication. RESULTS: When responses were averaged across the post-dose times, gabapentin: (1) significantly increased the temporal summation pain threshold in skin compared with placebo (P = .03); (2) significantly reduced the area under the pain intensity curve to hypertonic saline injections in the muscle (P = .02); and (3) significantly reduced the area of pain evoked by hypertonic saline (P = .03). CONCLUSIONS: Gabapentin reduces temporal summation of skin stimuli at pain threshold intensities; this may have potential as a biomarker for drugs with efficacy on neurogenic pain. The data also suggest that tonic muscle pain is responsive to gabapentin treatment and suggest further clinical studies.
Udgivelsesdato: null-null
OriginalsprogEngelsk
TidsskriftRegional Anesthesia and Pain Medicine
Vol/bind32
Nummer5
Sider (fra-til)382-8
Antal sider6
ISSN1098-7339
DOI
StatusUdgivet - 2007

Se relationer på Aarhus Universitet Citationsformater

ID: 10560052